Dhruva Mitul Dave

Dr. Dhruva Mitul Dave

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2024 in Medicina
Verified
Journal Article
Open access
PDF file
DDDhruva Mitul Dave
Dhruva Mitul Dave
HPHeidi E. Page
Heidi E. Page
ACAakriti R Carrubba
Aakriti R Carrubba
Endometriosis, an inflammatory disease primarily affecting the pelvis and peritoneum, manifests with pelvic pain, dysmenorrhea, dyschezia, dyspareunia, and infertility. Despite its ubiquity, the management of endometriosis is challenging due to its heterogeneous presentation, limitations in diagnostic methods, variable therapeutic responses, and personal and socio-cultural impact on quality of life. This review attempts to consolidate the current literature on endometriosis occurring during and beyond menopause, and to present details regarding management strategies that take into account individual outcomes and goals when managing this condition. The topics included in this review are the clinical features and differential diagnosis of pelvic pain in postmenopausal patients, imaging considerations, serum and laboratory biomarkers, indications for surgery, the principles of hormone replacement therapy, the de novo development of endometriosis after menopause, and malignant transformation. Each topic includes a summary of the current literature, utilizing clinical research, case reports, and expert opinion. Despite a better understanding of the impact of endometriosis beyond menopause, there are many limitations to this condition, specifically with regard to cancer risk and indications for surgery. The existing evidence supports the use of shared decision making and the incorporation of patient preferences in guiding clinical management. Future research endeavors must shed light on the natural history of postmenopausal endometriosis through longitudinal studies in order to foster a deeper understanding of its complicated disease course across women’s lifespans.

24 February 2023 in International Surgery Journal
Verified
Journal Article
Open access
PDF file
DDDhruva Mitul Dave
Dhruva Mitul Dave
JKJaydip R. Kavthiya
Jaydip R. Kavthiya
DGDarshan J. Gajera
Darshan J. Gajera
Dermoid cysts are benign congenital tumours of ectoderm origin usually arising from the midline where the fusion of embryonic structures of both sides occurs. They are true hamartomas focal malformations that can resemble neoplasms grossly and even microscopically. We hereby presented a case of a 25 year old male presented with complaints of a midline neck swelling for 5 years which was found just beneath a symbol tattooed in the skin overlying the swelling. The USG, fine needle aspiration cytology and multislice CT scan reports strongly suggested findings of a dermoid cyst. However, there was a diagnostic challenge faced when chest CT suggested old granulomatous changes around the swelling region. After thorough history taking, physical examination and radiological investigations, the swelling was successfully excised with a complete margin which was sent for histo-pathological examination, results of which correlated with the initial diagnosis of it being a dermoid cyst with foreign-body reactions.

27 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SMSimon M. Manga
Simon M. Manga
DDDhruva Mitul Dave
Dhruva Mitul Dave
ENEmmanuel Nshom
Emmanuel Nshom
KNKathleen Nulah
Kathleen Nulah
CKComfort Ketu
Comfort Ketu
RARebecca Arend
Rebecca Arend
Introduction: Human papillomavirus (HPV) types 16 and 18 are responsible for over 70% of cervical cancers worldwide. However, emerging evidence from sub-Saharan Africa suggests that non-HPV16/18 high-risk types may contribute substantially to cervical neoplasia. This study described the distribution of high-risk HPV among histologically confirmed CIN2+ lesions in Cameroon.,Methods: We conducted a descriptive study using secondary data from the Cameroon. Data were collected from women diagnosed with histologically confirmed CIN2+ lesions from 2020 to 2025. Sociodemographic, clinical, pathological, and HPV testing data were analyzed using descriptive statistics. HPV infections were categorized as HPV16, HPV18, or non-HPV16/18 types.,Results: 166 women with CIN2+ lesions were included in the study. Of these, 134 (80.7%) were positive for high-risk HPV and 32(19.3%) were HPV negative. Among the HPV-positives, 68(50.7%) were infected with HPV16 and/or HPV18 and 66(49.3%) with a pool of 12 non-HPV16/18 types. No sociodemographic or clinical characteristics differed significantly between the HPV16/18 and the non-HPV16/18 groups. Overall, HPV16 and HPV18 represented 41.0% of all CIN2+ lesions, whereas the pool of 12 non-HPV16/18 types represented 39.8% and HPV-negative lesions represented 19.3%. The pool of 12 non-HPV16/18 types represented the largest category of lesions across CIN2 (43.8%), CIN3 (51.2%), and ICC/micro-invasive disease (34.6%).,Conclusion: HPV16 and HPV18 were detected in less than half of all cases. The non-HPV16/18 types were substantially detected in CIN2, CIN3, and ICC/micro-invasive disease, underscoring the need for comprehensive HPV genotyping studies and ongoing surveillance to inform cervical cancer prevention strategies in the region.

12 January 2026 in Targets
Verified
Journal Article
Open access
PDF file
EOEmily O'Brien
Emily O'Brien
DDDhruva Mitul Dave
Dhruva Mitul Dave
AKAbbie Kleckley
Abbie Kleckley
FOFibiana Oladipo
Fibiana Oladipo
CMChristopher M. Mayer
Christopher M. Mayer
RARebecca Arend
Rebecca Arend
Background/Objectives: This pilot study investigates the feasibility of using patient-derived microtumors (PDMs) to assess chemotherapy response in epithelial ovarian cancer. Methods: Fresh tissue from 10 patients was used to develop PDMs, which were then tested against carboplatin/paclitaxel, carboplatin/docetaxel, and carboplatin/pegylated liposomal doxorubicin (PLD). Of the 10 PDMs, 3 were obtained from primary debulking surgery (PDS), and 7 were obtained at the time of interval debulking surgery following neoadjuvant chemotherapy. Results: When looking at PDMs derived from tissue collected at the time of PDS, we found that 100% of PDMs demonstrated a full response to carboplatin/PLD, while 30% showed a full response to all regimens, all of which were derived from high-grade serous carcinoma during PDS. The remaining PDMs showed moderate responses to carbo/taxol and carbo/doce. Conclusions: This study suggests that PDMs can be used to assess the efficacy of chemotherapy regimens, as a hypothesis-generating step toward future predictive validation.

29 October 2026 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
DDDhruva Mitul Dave
Dhruva Mitul Dave
RARebecca Arend
Rebecca Arend
CICharles Leath III
Charles Leath III
MTMichael D. Toboni
Michael D. Toboni
NWNicolas Wentzensen
Nicolas Wentzensen
MCMegan A. Clarke
Megan A. Clarke